H Pylori Eradication Therapy Curbs Risk for Stomach Cancer H Pylori Eradication Therapy Curbs Risk for Stomach Cancer
Results of a large retrospective study support the potential for substantial stomach cancer prevention in the United States through H pylori screening and treatment.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 5, 2023 Category: Cancer & Oncology Tags: Gastroenterology News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth in base business of both divisions in the first quarter; Group sales decline due to expected drop in demand for COVID-19 tests
As expected, significantly lower demand for COVID-19 tests leads to a decrease inGroup sales (-3%1 at constant exchange rates [CER] and -7% in Swiss francs); excluding this effect, Group sales grow 8%Pharmaceuticals Divisionsales up 9%; strong demand for newer medicines; Vabysmo for severe eye diseases is already the strongest growth driverDiagnostics Division base business grows 4%, whiledivisional salesare 28% lower due to exceptionally high demand for COVID-19 tests in the first quarter of 2022Highlights in the first quarter:US approval of Polivy (first-line treatment for an aggressive form of blood cancer)EU approva...
Source: Roche Investor Update - April 26, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth in base business of both divisions in the first quarter; Group sales decline due to expected drop in demand for COVID-19 tests
Basel, 26 April 2023As expected, significantly lower demand for COVID-19 tests leads to a decrease inGroup sales (-3%1 at constant exchange rates [CER] and -7% in Swiss francs); excluding this effect, Group sales grow 8%Pharmaceuticals Divisionsales up 9%; strong demand for newer medicines; Vabysmo for severe eye diseases is already the strongest growth driverDiagnostics Division base business grows 4%, whiledivisional salesare 28% lower due to exceptionally high demand for COVID-19 tests in the first quarter of 2022Highlights in the first quarter:US approval of Polivy (first-line treatment for an aggressive form of blo...
Source: Roche Media News - April 26, 2023 Category: Pharmaceuticals Source Type: news
No Survival Benefit With NAC for Advanced Stomach Cancer No Survival Benefit With NAC for Advanced Stomach Cancer
Neoadjuvant chemotherapy did not improve survival in elderly patients undergoing gastrectomy for advanced gastric cancer. The study was published as a preprint and has not yet been peer reviewed.First Look (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 21, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Janssen Marks First Approval Worldwide for AKEEGA ® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorization for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations
BEERSE, Belgium, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission (EC) has granted marketing authorisation for AKEEGA® (niraparib and abiraterone acetate [AA]), in the form of a dual action tablet (DAT), given with prednisone or prednisolone, for the treatment of adults with metastatic castration-resistant prostate cancer (mCRPC) and BRCA1/2 mutations (germline and/or somatic) in whom chemotherapy is not clinically indicated.2Prostate cancer is the most common cancer in men in Europe, and the sixth-highest cause of cancer-related death worldwide.1...
Source: Johnson and Johnson - April 21, 2023 Category: Pharmaceuticals Tags: Innovation Source Type: news
'Heavy' night sweats could signal 7 types of cancer - what to look for
This symptom could easily be mistaken for other less serious health issues, such as a flu or a stomach bug. (Source: Daily Express - Health)
Source: Daily Express - Health - April 19, 2023 Category: Consumer Health News Source Type: news
Palliative Interventions for Advanced Gastric Cancer Palliative Interventions for Advanced Gastric Cancer
Which palliative treatment modalities should be considered for patients with advanced forms of gastric cancer?Chinese Clinical Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 17, 2023 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Inflammation May Be the Culprit Behind Our Deadliest Diseases
In the early days of my medical residency, I met a man whom we’ll call Jason. He arrived to our emergency room on a holiday, nonchalant yet amiable, and complained of mild chest pain. Jason was tall and trim, with a strong South Boston accent and fingertips still faintly stained from his last home-improvement project. He was only 45 years old, but he looked much younger. He didn’t smoke, barely drank alcohol, and his cholesterol levels had always been normal. No one in his family had a history of heart disease. He asked us if we could work quickly—he wanted to be home for dinner with his daughters.
[time-...
Source: TIME: Health - April 11, 2023 Category: Consumer Health News Authors: Shilpa Ravella Tags: Uncategorized freelance health Source Type: news
Update on IMBRUVICA ® (ibrutinib) U.S. Accelerated Approvals for Mantle Cell Lymphoma and Marginal Zone Lymphoma Indications
HORSHAM, Pa., April 6, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson, in collaboration with its alliance partner, Pharmacyclics, an AbbVie Company, announced today the intent to voluntarily withdraw the U.S. indications for IMBRUVICA® (ibrutinib) for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy, and for the treatment of patients with marginal zone lymphoma (MZL) who require systemic therapy and have received at least one prior anti-CD20-based therapy. This decision was made in consultation with the U.S. Food and Drug Administration (FDA), c...
Source: Johnson and Johnson - April 6, 2023 Category: Pharmaceuticals Tags: Latest News Source Type: news
Science Saturday: Igniting the interest of young cancer researchers
The 2022 SPARK scholars gather for a photo before the Mayo Clinic SPARK Mini Science Fair on Mayo Clinic's campus in Jacksonville, Florida. Back row: Sara Wasserman, Krish Relan, Nyla Searl, Manish Kota, William Li, Garrett Davidsen, Riya Kar, Ella McCarthy. Front row: Kristi Biswas, Ysabella Wijaya, Yangying Jiang, Katie Shapiro, Esinam Ekpeh, Nia Atcherson, Katherine Jones and Hazel Parent. Not pictured: Jessica Desgroseilliers. "My mother was diagnosed with stage 4 stomach cancer when I… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - April 1, 2023 Category: Databases & Libraries Source Type: news
CEUS can rule out small bowel ischemia
Contrast-enhanced ultrasound (CEUS) can be useful in being a secondary imagin...Read more on AuntMinnie.comRelated Reading:
CEUS better than MRI for diagnosing liver, kidney tumors
Modified CEUS method does well in categorizing liver lesions
CEUS bests CT in early gastric cancer staging
CEUS-guided biopsy shows superiority in liver imaging
Prediction model with contrast US can gauge prostate cancer risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 31, 2023 Category: Radiology Source Type: news
H. Pylori Infection Negatively Modifies Genetically Increased Risk for Gastric Cancer
THURSDAY, March 30, 2023 -- Helicobacter pylori (H. pylori) infection modifies the increased risk for gastric cancer associated with germline pathogenic variants in cancer-predisposing genes, according to a study published in the March 30 issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 30, 2023 Category: Pharmaceuticals Source Type: news
A 'Double Whammy' for Gastric Cancer Risk
(MedPage Today) -- The combined effect of certain germline pathogenic variants and Helicobacter pylori infection were linked with large increases in gastric cancer risk, according to results from a Japanese study.
By age 85, the cumulative risk... (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - March 29, 2023 Category: Gastroenterology Source Type: news
Gene Variants Plus H pylori Increase Risk of Gastric Cancer Gene Variants Plus H pylori Increase Risk of Gastric Cancer
Individuals with inherited pathogenic variants in genes associated with homologous recombination of DNA who also had H pylori infections had a 3-fold higher risk for gastric cancer vs infected noncarriers.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 29, 2023 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Andrew Lloyd Webber ’s Son Nicholas Dies After Battle With Cancer
Nicholas Lloyd Webber, the Grammy-nominated composer, record producer and eldest son of Andrew Lloyd Webber, died Saturday (March 25) in England after a protracted battle with gastric cancer and pneumonia. He was 43. “His whole family is gathered together and we are all totally bereft,” the…#nicholaslloydwebber #grammy #andrewlloydwebber #basingstoke #broadway #badcinderella #lies #littleprince #sarahhugill #imogen (Source: Reuters: Health)
Source: Reuters: Health - March 25, 2023 Category: Consumer Health News Source Type: news
